Measurement of regional myocardial blood flow in hypertrophic cardiomyopathy: application of the first-pass flow model using [13N]ammonia and PET. 1989

K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
Third Department of Internal Medicine, Chiba University School of Medicine, Japan.

Positron emission tomography (PET) has become an important tool in the study of regional myocardial blood flow. The purpose of the present study was to measure regional myocardial blood flow using dynamic [13N]ammonia PET and the first-pass flow model. Thirteen patients with hypertrophic cardiomyopathy, and with a considerably thickened ventricular wall (25 mm or greater), were selected for the study in order to minimize errors due to spillover of radioactivity from blood to the myocardium and to the underestimation of myocardial activity caused by the partial volume effect. Arterial input function was determined by assigning a region of interest to the left atrial cavity on the PET images. Using left atrial and myocardial time-activity curves, regional myocardial blood flow was calculated using the first-pass flow model. Mean myocardial blood flow ranged from 47.8 to 76.5 ml/min per 100 g (63.0 +/- 9.4). Regional myocardial blood flow in the septum was significantly lower than in the anterior and lateral walls of the left ventricle (P less than .01). These results indicate the potential usefulness of dynamic PET in the measurement of regional myocardial blood flow in man.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009590 Nitrogen Radioisotopes Unstable isotopes of nitrogen that decay or disintegrate emitting radiation. N atoms with atomic weights 12, 13, 16, 17, and 18 are radioactive nitrogen isotopes. Radioisotopes, Nitrogen
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000641 Ammonia A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.

Related Publications

K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
August 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
June 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
November 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
September 1992, Circulation,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
September 2012, Nuclear medicine communications,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
January 2017, European journal of nuclear medicine and molecular imaging,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
January 1997, Cardiology,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
February 2012, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
February 2021, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
K Yoshida, and M Endo, and T Himi, and A Kagaya, and Y Masuda, and Y Inagaki, and H Fukuda, and T Iinuma, and T Yamasaki, and N Fukuda
February 2020, Nuclear medicine communications,
Copied contents to your clipboard!